Trial Profile
A comparison of the effects of insulin Detemir with insulin Glargine on weight gain in female adolescents and young adults with Type 1 Diabetes on a basal bolus regime
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2019
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- 17 May 2019 Status changed from active, no longer recruiting to discontinued.
- 28 Jan 2016 Accrual to date is 86% according to United Kingdom Clinical Research Network record.
- 28 Jan 2016 According to United Kingdom Clinical Research Network record, Status changed from recruiting to active, no longer recruiting.